Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 18
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P45.08 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China
00:00 - 00:00 | Presenter: Shun Lu
- Abstract
Loading...
-
+
P49 - Novel Therapeutics and Targeted Therapies - EGFR Major
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 1
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P49.01 - Drug Holiday Based on Minimal Residual Disease Status After Local Therapy Following EGFR-TKI Treatment for Patients With Advanced NSCLC
00:00 - 00:00 | Presenter: Song Dong
- Abstract
Loading...
-
+
P52 - Novel Therapeutics and Targeted Therapies - KRAS
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 5
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P52.02 - High SHP2 Expression Determines the Efficacy of PD-1/PD-L1 Inhibitors in Advanced KRAS Mutant Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Hui-Bo Feng
- Abstract
Loading...
-
+
P57 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - ICI Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 16
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P57.15 - Safety and Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Low Creatinine Clearance Rate
00:00 - 00:00 | Presenter: Jia-Yi Deng
- Abstract
Loading...
-
+
MA02 - RET and Novel Combinations of Osimertinib
- Type: Mini Oral
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 8
- Coordinates: 9/08/2021, 09:30 - 10:30, Program Auditorium
-
+
MA02.02 - Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer
09:35 - 09:40 | Presenter: Qing Zhou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ES11 - Small Cell Lung Cancer: Recent Preclinical Advances and Emerging Approaches to Therapy*
- Type: Education Session
- Track: Small Cell Lung Cancer/ NET
- Presentations: 6
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Ticiana Leal
- Coordinates: 9/10/2021, 11:15 - 11:50, Program Auditorium
-
+
ES11.03 - Emerging Strategies in ES-SCLC in the Frontline
11:19 - 11:21 | Presenter: Qing Zhou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
WS06 - Joint IASLC - CAALC - CSCO Workshop: Looking Toward the Future: Recognizing and Curing Lung Cancer
- Type: Workshop
- Track: N.A.
- Presentations: 9
- Moderators:Caicun Zhou
- Coordinates: 9/11/2021, 22:15 - 23:45, Program Auditorium
-
+
WS06.06 - Drug Holiday Based on Minimal Residual Disease Status After Local Therapy Following EGFR-TKI Treatment for Patients With Advanced NSCLC
23:03 - 23:13 | Presenter: Song Dong
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
WS06.07 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China
23:13 - 23:23 | Presenter: Shun Lu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA16 - Clinical Impact of Liquid Biopsy for Patients with NSCLC
- Type: Oral
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
- Presentations: 6
- Moderators:Sarah B Goldberg
- Coordinates: 9/12/2021, 20:00 - 21:00, Program Auditorium
-
+
OA16.03 - Matched Targeted Therapy by cfDNA of CSF Beyond Leptomeningeal Metastases Progression Upon Osimertinib in EGFR-Mutated NSCLC Patients
20:20 - 20:30 | Presenter: Mei-Mei Zheng
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
